New technology using drug eluting balloon therapy brings 66 year old to life in Bangalore
66 year old Saraswati (name changed) from Bangalore becomes the first to get cured of peripheral arterial disease (leg attack) using the first ever minimal invasive drug eluting balloon therapy.
Saraswati, started experiencing pain in her lower right limb a few months back while performing her daily routine activities. But she did not take it seriously. She ignored it assuming it to be one of effects of her increasing age. But eventually the pain got more and more severe over the next few weeks and worsened to the effect of her not being able to walk for even a few meters. Her daily routine activities got hampered. Her condition worsened day by day. It was then she consulted Dr. Suresh at Jain Institute of Vascular Sciences (JIVAS) Bangalore.
On initial examination of the limb, Dr. Suresh could detect pulse only in the right superficial femoral artery of the right limb. The pulses in the deeper portions of the artery were not palpable. At JIVAS she further conducted a few tests and her angiogram showed critical stenosis (abnormal narrowing of the blood vessels) of her right femoral artery in the thigh. This stenosis led to insufficient blood supply to the right limb and this was causing pain and discomfort. She was advised to undergo a right superficial femoral artery angioplasty and was recommended for the IN.PACT DEB balloon by the doctor. Dr. Suresh said “The new technology of drug eluting balloon is the emerging choice for first-line treatment of peripheral arterial disease since it gives better outcomes in terms of restenosis. Restenosis ie re narrowing of the blood vessels after peripheral arterial angioplasty, is one of the major problem limiting its long-term efficiency and patency, and may lead to recurrent symptoms, and since superficial femoral arteries are muscular (distributing) arteries, they have high rates of restenosis after percutaneous interventions as compared to the coronary interventions. This rapid drug transfer reduces the chances of restenosis in patients. The Paclitaxel drug that gets naturally and rapidly absorbed deep into the arteries due to its hydrophobic and lipophilic properties binds to the wall and penetrates the vessel wall deep into the media and adventitia, addressing the causes of restenosis.”
Saraswati became the first patient from Bangalore to get the IN.PACT DEB stent implanted and now she can perform her daily activities effortlessly without experiencing any pain and also be assured that this would not recur.
Source: Press Release